Catalent, Inc.
CTLTDelisted Dec 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596783
Catalent, Inc. was delisted on Dec 18, 2024; its insiders filed their last Form 4 on Dec 18, 2024; 472 institutions reported holding it in 13F filings for Q3 2024, worth $10.8B in total; Elliott Investment Management was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Catalent, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Catalent, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Stahl Jack L | Director | 0 | Dec 18, 2024 | 0 |
| Classon Rolf A | Director | 0 | Dec 18, 2024 | 0 |
| Damelio Frank A | Director | 0 | Dec 18, 2024 | 0 |
| Morel Donald E Jr | Director | 0 | Dec 18, 2024 | 0 |
| Lucier Gregory T | Director | 0 | Dec 18, 2024 | 0 |
| Greisch John J | Executive Chair | 0 | Dec 18, 2024 | 0 |
| Carroll J Martin | Director | 0 | Dec 18, 2024 | 0 |
| Masanovich Matti | SVP, Chief Financial Officer | 0 | Dec 18, 2024 | 0 |
| Gennadios Aristippos | Group Pres. Pharma & Consumer | 0 | Dec 18, 2024 | 0 |
| Evoli Lisa | SVP, Chief HR Officer | 0 | Dec 18, 2024 | 0 |
| Maselli Alessandro | President & CEO | 0 | Dec 18, 2024 | 0 |
| Gunther Scott | SVP, Quality & Reg. Affairs | 0 | Dec 18, 2024 | 0 |
| Ferraro Joseph Anthony | SVP, General Counsel, CCO | 0 | Dec 18, 2024 | 0 |
| Okey Stephanie | Director | 0 | Dec 18, 2024 | 0 |
| Hatzfeld Michael | Chief Accounting Officer | 0 | Dec 18, 2024 | 0 |
| Barg Steven | Director | 0 | Dec 18, 2024 | 0 |
| Barber Michael J | Director | 0 | Dec 18, 2024 | 0 |
| Hopson Ricky | Pres. BioProduct Delivery, CoS | 0 | Dec 18, 2024 | 0 |
| Ryan Michelle R | Director | 0 | Dec 18, 2024 | 0 |
| McErlane David | Group President, Biologics | 0 | Dec 18, 2024 | 0 |
| Kreuzburg Christa | Director | 18,283 | Jan 29, 2024 | 0 |
| Fasman Steven L | EVP & Chief Admin Officer | 72,380 | Dec 12, 2023 | 0 |
| Arnold Jonathan | SVP, CCO & Div. Head BioP Del. | 55,896 | Dec 12, 2023 | 0 |
| Pravda Ricardo | Chief Transformation Officer | 29,522 | Dec 12, 2023 | 0 |
| Grippo Michael J | SVP, Strategy & Corp. Dev. | 23,725 | Dec 12, 2023 | 0 |
| Carletti Lorenzo | SVP Global Ops Ph & Cons Hlth | 8,505 | Dec 12, 2023 | 0 |
| Hawkeswood Thomas W | Pres. Pharma Prod Delivery Div | 7,412 | Dec 12, 2023 | 0 |
| Hunt Patricia | Pres. Consumer Health Div | 11,106 | Dec 12, 2023 | 0 |
| Lickfold Charles | SVP, CIO | 10,892 | Dec 12, 2023 | 0 |
| Crane Rosemary A | Director | 23,873 | Oct 31, 2023 | 0 |
| Flynn Karen | Director | 24,339 | Oct 31, 2023 | 0 |
| Balachandran Madhavan | Director | 27,441 | Oct 31, 2023 | 0 |
| Zayas Ricardo | SVP, Operations, Biologics NA | 6,223 | Aug 3, 2023 | 0 |
| Santiago Karen Murphy | VP & Chief Accounting Officer | 4,763 | Aug 3, 2023 | 0 |
| Gargiulo Mario | SVP, Ops, Biologics Europe | 5,676 | May 3, 2023 | 0 |
| Boerman Manja | Pres. BioModalities Division | 14,414 | May 3, 2023 | 0 |
| Zippelius Peter | Director | 11,979 | Oct 31, 2022 | 0 |
| Riley Michael A. | Pres. Bio Product Delivery Div | 6,592 | Aug 30, 2022 | 0 |
| Chiminski John R | Executive Chair | 229,888 | Aug 26, 2022 | 0 |
| Schmidt Kay A | SVP, Enterprise Functions | 17,388 | Aug 26, 2022 | 0 |
| Castellano Thomas P | SVP, Chief Financial Officer | 20,099 | Aug 26, 2022 | 0 |
| Whitlow Ricci S | President, CSS | 2,923 | Jan 24, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2021 (view filing) | Jul 15 | 1 day | Fasman Steven LSVP & General Counsel | SSale | −4.50K | $109.86 | −$494.4K | −6.1%68.9K after | 2 lots |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Arnold JonathanPres. Oral & Specialty Deliv. | SSale | −120 | $113.05 | −$13.6K | −0.3%38.5K after | |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Chiminski John RChair & CEO | SSale | −11.1K | $113.05 | −$1.26M | −6.8%152.5K after | |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Fasman Steven LSVP & General Counsel | SSale | −1.55K | $113.05 | −$175.1K | −2.2%67.4K after | |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Gennadios AristipposPresident Softgel & Oral Tech | SSale | −465 | $113.05 | −$52.6K | −0.9%50.9K after | |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Grippo Michael JSVP, Strategy & Corp. Dev. | SSale | −451 | $113.05 | −$51.0K | −2.6%16.6K after | |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Gunther ScottSVP, Quality & Reg. Affairs | SSale | −1.08K | $113.04 | −$122.0K | −6.5%15.4K after | 2 lots |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Maselli AlessandroPresident & COO | SSale | −993 | $113.05 | −$112.3K | −5.1%18.6K after | |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Pravda RicardoSVP & Chief HR Officer | SSale | −458 | $113.05 | −$51.8K | −4.1%10.6K after | |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Hopson RickyVP, Chief Accounting Officer | SSale | −360 | $113.05 | −$40.7K | −2.2%16.1K after | |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Schmidt Kay ASVP, Technical Operations | SSale | −547 | $113.05 | −$61.8K | −3.9%13.3K after | |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Castellano Thomas PSVP, Chief Financial Officer | SSale | −555 | $113.05 | −$62.7K | −3.7%14.5K after | |
| Aug 23, 2021 (view filing) | Dec 19, 2019-Jan 13, 2020 | 613 daysLate | Grippo Michael JSVP, Strategy & Corp. Dev. | SSale | −5.93K | $55.94 | −$331.9K | −33.7%11.6K after | 3 lots |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Arnold JonathanPres. Oral & Specialty Deliv. | SSale | −452 | $131.13 | −$59.3K | −1.0%46.7K after | 2 lots |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Chiminski John RChair & CEO | SSale | −44.5K | $131.06 | −$5.83M | −16.2%229.9K after | 2 lots |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Fasman Steven LSVP & General Counsel | SSale | −6.11K | $131.13 | −$801.3K | −7.6%74.6K after | 2 lots |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Gennadios AristipposPresident Softgel & Oral Tech | SSale | −2.26K | $131.13 | −$296.6K | −3.8%57.5K after | 2 lots |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Grippo Michael JSVP, Strategy & Corp. Dev. | SSale | −1.70K | $131.13 | −$222.7K | −10.4%14.6K after | 2 lots |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Gunther ScottSVP, Quality & Reg. Affairs | SSale | −4.17K | $130.78 | −$545.7K | −18.8%18.1K after | 3 lots |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Maselli AlessandroPresident & COO | SSale | −3.74K | $131.13 | −$490.8K | −12.6%25.9K after | 2 lots |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Pravda RicardoSVP & Chief HR Officer | SSale | −692 | $131.13 | −$90.7K | −5.1%12.8K after | 2 lots |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Hopson RickyVP, Chief Accounting Officer | SSale | −1.47K | $131.13 | −$192.9K | −7.0%19.4K after | 2 lots |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Schmidt Kay ASVP, Technical Operations | SSale | −825 | $131.13 | −$108.2K | −4.9%16.0K after | 2 lots |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Castellano Thomas PSVP, Chief Financial Officer | SSale | −2.09K | $131.13 | −$274.5K | −10.6%17.7K after | 2 lots |
| Oct 5, 2021 (view filing) | Oct 1 | 4 days | Chiminski John RChair & CEO | SSale | −152.6K | $130.90 | −$20.0M | −51.8%142.1K after | 7 lots |
| Oct 5, 2021 (view filing) | Oct 1 | 4 days | Grippo Michael JSVP, Strategy & Corp. Dev. | SSale | −2.06K | $131.66 | −$270.6K | −14.1%12.5K after | 4 lots |
| Oct 5, 2021 (view filing) | Oct 1 | 4 days | Pravda RicardoSVP & Chief HR Officer | SSale | −4.91K | $132.68 | −$650.9K | −29.5%11.7K after | |
| Oct 6, 2021 (view filing) | Oct 4 | 2 days | Fasman Steven LSVP & General Counsel | SSale | −34.7K | $129.05 | −$4.48M | −37.8%57.1K after | 4 lots |
| Oct 6, 2021 (view filing) | Oct 4 | 2 days | Schmidt Kay ASVP, Technical Operations | SSale | −2.19K | $131.25 | −$287.6K | −13.7%13.8K after | |
| Oct 18, 2021 (view filing) | Oct 14 | 4 days | Arnold JonathanPres. Oral & Specialty Deliv. | SSale | −1.66K | $129.41 | −$215.0K | −3.6%45.1K after | |
| Oct 21, 2021 (view filing) | Oct 20 | 1 day | Castellano Thomas PSVP, Chief Financial Officer | SSale | −2.31K | $134.00 | −$309.1K | −13.0%15.4K after | |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Arnold JonathanPres. Oral & Specialty Deliv. | SSale | −10.7K | $140.02 | −$1.49M | −20.3%42.0K after | |
| Nov 24, 2021 (view filing) | Nov 23 | 1 day | Lucier Gregory TDirector | SSale | −5.07K | $127.35 | −$645.4K | −100.0%0 after | 2 lots |
| Dec 1, 2021 (view filing)8:35 PM ET | Nov 30 | 1 day | Zippelius PeterDirector | SSale | −3.00M | $129.30 | −$387.9M | −38.3%4.82M after | |
| Jan 11, 2022 (view filing) | Jan 10 | 1 day | Flynn KarenChief Commercial Officer | SSale | −2.47K | $116.64 | −$288.3K | −6.9%33.2K after | |
| Jan 24, 2022 (view filing) | Jan 21 | 3 days | Whitlow Ricci SPresident, CSS | SSale | −184 | $102.37 | −$18.8K | −5.9%2.92K after | |
| Feb 1, 2022 (view filing) | Jan 31 | 1 day | Hopson RickyVP, Chief Accounting Officer | SSale | −2.33K | $103.39 | −$240.4K | −12.0%17.1K after | |
| Feb 8, 2022 (view filing) | Feb 6 | 2 days | Zippelius PeterDirector | SSale | −487.1K | $102.65 | −$50.0M | −10.1%4.33M after | |
| Jun 13, 2022 (view filing) | Jun 10 | 3 days | Fasman Steven LSVP & General Counsel | SSale | −5.00K | $107.07 | −$535.4K | −8.2%56.2K after | 2 lots |
| Jun 13, 2022 (view filing) | Jun 10 | 3 days | Gargiulo MarioSVP Global Ops Large Molecule | SSale | −118 | $106.59 | −$12.6K | −2.5%4.64K after | |
| Jul 28, 2022 (view filing) | Jul 26 | 2 days | Arnold JonathanSVP & Chief Commercial Ofcr | SSale | −94 | $106.90 | −$10.0K | −0.2%48.7K after | |
| Jul 28, 2022 (view filing) | Jul 26 | 2 days | Carletti LorenzoSVP Global Ops Ph & Cons Hlth | SSale | −631 | $106.90 | −$67.5K | −17.6%2.95K after | |
| Jul 28, 2022 (view filing) | Jul 26 | 2 days | Castellano Thomas PSVP, Chief Financial Officer | SSale | −347 | $106.90 | −$37.1K | −2.3%15.1K after | |
| Jul 28, 2022 (view filing) | Jul 26 | 2 days | Chiminski John RExecutive Chair | SSale | −9.69K | $106.90 | −$1.04M | −6.8%132.4K after | |
| Jul 28, 2022 (view filing) | Jul 26 | 2 days | Fasman Steven LEVP & Chief Admin Officer | SSale | −2.55K | $106.90 | −$272.2K | −4.5%53.7K after | |
| Jul 28, 2022 (view filing) | Jul 26 | 2 days | Gargiulo MarioSVP Global Ops Biologics | SSale | −969 | $106.90 | −$103.6K | −20.9%3.67K after | |
| Jul 28, 2022 (view filing) | Jul 26 | 2 days | Gennadios AristipposGroup Pres. Pharma & Consumer | SSale | −403 | $106.90 | −$43.1K | −0.5%79.8K after | |
| Jul 28, 2022 (view filing) | Jul 26-27 | 2 days | Grippo Michael JSVP, Strategy & Corp. Dev. | SSale | −797 | $107.27 | −$85.5K | −4.5%17.0K after | 2 lots |
| Jul 28, 2022 (view filing) | Jul 26-27 | 2 days | Gunther ScottSVP, Quality & Reg. Affairs | SSale | −844 | $107.26 | −$90.5K | −3.6%22.4K after | 2 lots |
| Jul 28, 2022 (view filing) | Jul 26-27 | 2 days | Hopson RickyPres, Clinical Dev & Supply | SSale | −903 | $107.40 | −$97.0K | −5.0%17.1K after | 2 lots |